Updated on 16 September 2015
Pelican BioThermal offers the widest range of temperature-controlled; thermally protect packaging and service solutions to the global lifesciences industry
Singapore: Pelican BioThermal, a global leader providing the broadest and most innovative range of temperature-controlled packaging solutions serving the lifesciences industry, announced its new partnership with Asia's Zuellig Pharma.
The pharma partnership further aligns with Pelican BioThermal's plans to grow in the region and the new contract, will see Zuellig Pharma in Vietnam utilize reusable Crēdo products and Crēdo Cube for parcel shipments. Additional products being used to transport pharma products include the Crēdo Xtreme for bulk shipment, ProMed and DuraCube. The benefits for the deployment of the Crēdo products include robust controlled-temperature reliability based on elimination of thermal excursions and low cost of ownership due to the reusable nature of the product.
"We are very excited about the new relationship with Zuellig Pharma and are honored to introduce Pelican BioThermal products and services to them as part of our expanding global network," said Mr David Williams, president of Pelican BioThermal. "The introduction of our products and support services are a cornerstone of Zuellig Pharma's Asian strategy beginning with Vietnam, which is the first of 12 Asian countries that will utilize our products for their operations, over the next 18 months. With our Asian headquarters being based in Singapore we are ideally placed to support Zuellig Pharma with replacement parts for refurbishment, offer ongoing training, in addition to providing backup if they need further assistance with any additional service volume."
"Zuellig Pharma is committed to providing innovative solutions that meet our high quality standards and support the continuous enhancement of the services to our clients and customers," said Mr Darren Wedding, senior vice-president, operations of Zuellig Pharma. "The deployment of the Crēdo Cube will only further strengthen Zuellig's leading position in the provision of cold chain solutions for the pharmaceutical industry."